Summary
In trauma to, and diseases of, the central nervous system (CNS), apoptotic events are frequently observed in and around areas of damage. Human embryonic stem cells (hESCs) and their progeny have been suggested as possible therapeutic agents in the treatment of CNS diseases. The success of stem cell transplantation not only depends on the capacity of these cells to retain their functionality after transplant into the CNS but also on their ability to resist the in situ environmental cues that may lead to apoptosis. Although there are many methods used to detect apoptosis, the assessment of apoptosis in adherent cultures of primary stem cells and their progeny is more limited. We describe a series of protocols we have used to assess apoptosis in these cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Przedborski, S. (2005) Pathogenesis of nigral cell death in Parkinson’s disease Parkinsonism Relat. Disord. 11, S3–S7.
Hovelmeyer, N., Hao, Z., Kranidioti, K., et al. (2005) Apoptosis of oligodendrocytes via Fas and TNF-R1 is a key event in the induction of experimental autoimmune encephalomyelitis. J. Immunol. 175, 5875–5884.
Huang, Y., Erdmann, N., Peng, H., Zhao, Y., and Zheng, J. (2005) The role of TNF related apoptosis-inducing ligand in neurodegenerative diseases. Cell Mol. Immunol. 2, 113–122.
Rosenberg, P. B. (2005) Clinical aspects of inflammation in Alzheimer’s disease. Int. Rev. Psych. 17, 503–514.
Mitsios, N., Gaffney, J., Kumar, P., Krupinski, J., Kumar, S., and Slevin, M. (2006) Pathophysiology of acute ischaemic stroke: an analysis of common signalling mechanisms and identification of new molecular targets. Pathobiology 73, 159–175.
Zhang, X., Alber, S., Watkins, S. C., et al. (2006) Proteolysis consistent with activation of caspase-7 after severe traumatic brain injury in humans. J. Neurotrauma 23, 1583–1590.
Lucchinetti, C., Bruck, W., Parisi, J., Scheithauer, B., Rodriguez, M., and Lassmann, H. (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 47, 707–717.
Barnett, M. H. and Prineas, J. W. (2004) Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann. Neurol. 55, 458–468.
Scolding, N. J. and Franklin, R. J. (1997) Remyelination in demyelinating disease. Baillieres Clin. Neurol. 6, 525–548.
Scolding, N., Franklin, R., Stevens, S., Heldin, C. H., Compston, A., and Newcombe, J. (1998) Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis. Brain 121, 2221–2228.
Hohlfeld, R. (2002) Myelin failure in multiple sclerosis: breaking the spell of Notch. Nat. Med. 8, 1075–1076.
Stangel, M. and Hartung, H. P. (2002) Remyelinating strategies for the treatment of multiple sclerosis. Prog. Neurobiol. 68, 361–376.
Patrikios, P., Stadelmann, C., Kutzelnigg, A., et al. (2006) Remyelination is extensive in a subset of multiple sclerosis patients. Brain 129, 3165–3172.
Barres, B. A., Hart, I. K., Coles, H. S., et al. (1992) Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70, 31–46.
Vartanian, T., Li, Y., Zhao, M., and Stefansson, K. (1995) Interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Mol. Med. 1, 732–743.
Peterson, J. W., Bo, L., Mork, S., Chang, A., Ransohoff, R. M., and Trapp, B. D. (2002) VCAM-1-positive microglia target oligodendrocytes at the border of multiple sclerosis lesions., J. Neuropathol. Exp. Neurol. 61, 539–546.
Fox, E. J. (2004) Immunopathology of multiple sclerosis. Neurology 63, S3–S7.
Talbott, J. F., Loy, D. N., Liu, Y., et al. (2005) Endogenous Nkx2.2+/Olig2+ oligodendrocyte precursor cells fail to remyelinate the demyelinated adult rat spinal cord in the absence of astrocytes. Exp. Neurol. 192, 11–24.
Barkho, B. Z., Song, H., Aimone, J. B., et al. (2006) Identification of astrocyte-expressed factors that modulate neural stem/progenitor cell differentiation. Stem Cells Dev. 15, 407–421.
Belmadani, A., Tran, P. B., Ren, D., and Miller, R. J. (2006) Chemokines regulate the migration of neural progenitors to sites of neuroinflammation. J. Neurosci. 26, 3182–3191.
Kadi, L., Selvaraju, R., de Lys, P., Proudfoot, A. E., Wells, T. N., and Boschert, U. (2006) Differential effects of chemokines on oligodendrocyte precursor proliferation and myelin formation in vitro. J. Neuroimmunol. 174, 133–146.
Learish, R. D., Brustle, O., Zhang, S. C., and Duncan, I. D. (1999) Intraventricular transplantation of oligodendrocyte progenitors into a fetal myelin mutant results in widespread formation of myelin. Ann. Neurol. 46, 716–722.
Cummings, B. J., Uchida, N., Tamaki, S. J., and Anderson, A. J. (2006) Human neural stem cell differentiation following transplantation into spinal cord injured mice: association with recovery of locomotor function. Neurol. Res. 28, 474–481.
Hardison, J. L., Nistor, G., Gonzalez, R., Keirstead, H. S., and Lane, T. E. (2006) Transplantation of glial-committed progenitor cells into a viral model of multiple sclerosis induces remyelination in the absence of an attenuated inflammatory response. Exp. Neurol. 197, 420–429.
Einstein, O., Fainstein, N., Vaknin, I., et al. (2007) Neural precursors attenuate autoimmune encephalomyelitis by peripheral immunosuppression. Ann. Neurol. 61, 209–218.
Einstein, O., Grigoriadis, N., Mizrachi-Kol, R., et al. (2006) Transplanted neural precursor cells reduce brain inflammation to attenuate chronic experimental autoimmune encephalomyelitis. Exp. Neurol. 198, 275–284.
Kerr, J. F., Wyllie, A. H., and Currie, A. R. (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239–257.
Walker, N. I., Harmon, B. V., Gobe, G. C., and c, J. F. (1988) Patterns of cell death. Methods Achiev. Exp. Pathol. 13, 18–54.
Cohen, J. J. (1993) Apoptosis. Immunol. Today 14, 126–130.
Stewart, B. W. (1994) Mechanisms of apoptosis: integration of genetic, biochemical, and cellular indicators. J. Natl. Cancer Inst. 86, 1286–1296.
Kanduc, D., Mittelman, A., Serpico, R., et al. (2002) Cell death: apoptosis versus necrosis (review). Int. J. Oncol. 21, 165–170.
Assuncao Guimaraes, C. and Linden, R. (2004) Programmed cell deaths. Apoptosis and alternative deathstyles. Eur. J. Biochem. 271, 1638–1650.
Duvall, E., Wyllie, A. H., and Morris., R. G. (1985) Macrophage recognition of cells undergoing programmed cell death (apoptosis). Immunology 56, 351–358.
Compton, M. M. (1992) A biochemical hallmark of apoptosis: internucleosomal degradation of the genome. Cancer Metastasis Rev. 11, 105–119.
Brown, D. G., Sun, X. M., and Cohen, G. M. (1993) Dexamethasone-induced apoptosis involves cleavage of DNA to large fragments prior to internucleosomal fragmentation. J. Biol. Chem. 268,3037–3039.
Ormerod, M. G., Sun, X. M., Snowden, R. T., Davies, R., Fearnhead, H., and Cohen, G. M. (1993) Increased membrane permeability of apoptotic thymocytes: a flow cytometric study. Cytometry 14, 595–602.
Cohen, G. M., Sun, X. M., Fearnhead, H., et al. (1994) Formation of large molecular weight fragments of DNA is a key committed step of apoptosis in thymocytes. J. Immunol. 153, 507–516.
Sun, X. M., Snowden, R. T., Dinsdale, D., Ormerod, M. G., and Cohen, G. M. (1994) Changes in nuclear chromatin precede internucleosomal DNA cleavage in the induction of apoptosis by etoposide. Biochem. Pharmacol. 47, 187–195.
Wyllie, A. H. (1980) Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284, 555–556.
Sgonc, R. and Wick, G. (1994) Methods for the detection of apoptosis. Int. Arch. Allergy Immunol. 105, 327–332.
Cohen, G. M., Sun, X. M., Snowden, R. T., Ormerod, M. G., and Dinsdale, D. (1993) Identification of a transitional preapoptotic population of thymocytes. J. Immunol. 151, 566–574.
Renvoize, C., Biola, A., Pallardy, M., and Breard, J. (1998) Apoptosis: identification of dying cells. Cell Biol. Toxicol. 14, 111–120.
Daniel, P. T. and Krammer, P. H. (1994) Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells. J. Immunol. 152, 5624–5632.
Zupo, S., Isnardi, L., Megna, M., et al. (1996) CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis. Blood 88, 1365–1374.
Gavrieli, Y., Sherman, Y., and Ben-Sasson, S. A. (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119, 493–501.
Mochizuki, H., Nakamura, N., Nishi, K., and Mizuno, Y. (1994) Apoptosis is induced by 1-methyl-4-phenylpyridinium ion (MPP+) in ventral mesencephalic-striatal co-culture in rat. Neurosci. Lett. 170, 191–194.
Portera-Cailliau, C., Sung, C. H., Nathans, J., and Adler, R. (1994) Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa. Proc. Natl. Acad. Sci. USA 91, 974–978.
Frankfurt, O. S., Robb, J. A., Sugarbaker, E. V., and Villa, L. (1996) Monoclonal antibody to single-stranded DNA is a specific and sensitive cellular marker of apoptosis. Exp. Cell Res. 226, 387–397.
Frankfurt, O. S. and Krishan, A. (2001) Identification of apoptotic cells by formamide-induced DNA denaturation in condensed chromatin. J. Histochem. Cytochem. 49, 369–378.
Johnson, V. L., Ko, S. C., Holmstrom, T. H., Eriksson, J. E., and Chow, S. C. (2000) Effector caspases are dispensable for the early nuclear morphological changes during chemical-induced apoptosis. J. Cell Sci. 113, 2941–2953.
Jones, R. A., Johnson, V. L., Buck, et al. (1998) Fas-mediated apoptosis in mouse hepatocytes involves the processing and activation of caspases. Hepatology 27, 1632–1642.
Dive, C., Gregory, C. D., Phipps, D. J., Evans, D. L., Milner, A. E., and Wyllie, A. H. (1992) Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochim. Biophys. Acta 1133, 275–285.
Sun, X. M., MacFarlane, M., Zhuang, J., Wolf, B. B., Green, D. R., and Cohen, G. M. (1999) Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J. Biol. Chem. 274, 5053–5060.
Kolenko, V. M., Uzzo, R. G., Bukowski, R., and Finke, J. H. (2000) Caspase-dependent and -independent death pathways in cancer therapy. Apoptosis 5, 17–20.
Nicotera, P. (2002) Apoptosis and age-related disorders: role of caspase-dependent and caspase-independent pathways. Toxicol. Lett. 127, 189–195.
Cregan, S. P., Dawson, V. L., and Slack, R. S. (2004) Role of AIF in caspase-dependent and caspase-independent cell death. Oncogene 23, 2785–2796.
Stefanis, L. (2005) Caspase-dependent and -independent neuronal death: two distinct pathways to neuronal injury. Neuroscientist 11, 50–62.
Kabir, J., Lobo, M., and Zachary, I. (2002) Staurosporine induces endothelial cell apoptosis via focal adhesion kinase dephosphorylation and focal adhesion disassembly independent of focal adhesion kinase proteolysis. Biochem. J. 367, 145–155.
Daniel, P. T., Sturm, I., Ritschel, S., Friedrich, K., Dorken, B., Bendzko, P., and Hillebrand, T. (1999) Detection of genomic DNA fragmentation during apoptosis (DNA ladder) and the simultaneous isolation of RNA from low cell numbers. Anal. Biochem. 266, 110–115.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Lund, B.T., Kelland, E.E. (2008). Measuring Apoptosis in Neural Stem Cells. In: Weiner, L.P. (eds) Neural Stem Cells. Methods in Molecular Biology™, vol 438. Humana Press. https://doi.org/10.1007/978-1-59745-133-8_19
Download citation
DOI: https://doi.org/10.1007/978-1-59745-133-8_19
Publisher Name: Humana Press
Print ISBN: 978-1-58829-846-1
Online ISBN: 978-1-59745-133-8
eBook Packages: Springer Protocols